How Long Can IPO Euphoria Last?

Just how much more optimism is out there for Uber, Slack, Palantir, and possibly Airbnb?

A Tough Week for Biotech, the Candidates' Whipping Boy Again

Talk among a mammoth field of presidential candidates about drug price controls and an expansion of Medicare isn't helping biotech and health care stocks.

A Bullish Play on Netflix

Netflix is bullish, but faces key resistance before it can make a big run higher.

Why This Market Is Not 'Overvalued', Plus a Play on Citigroup: Market Recon

Citi is severely undervalued, even as financials underperform.

Bulls Still Have the Advantage but Earnings Season May Contain Some Landmines

I want to see better stock picking and stronger momentum in individual stocks.

Keep on Truckin' With J.B. Hunt

Now is a good time to buy JBHT. Only on Wall Street can the best earnings ever be touted as 'bad news.'

Markets Have Bad Case of Jet Lag

Selling isn't too heavy, but neither is buying as markets appear ready to doze off -- looks like a pullback is in order.

4 Key Earnings Reports I'm Watching This Week

There are several story lines to watch as these companies report earnings.

Kass: A Week Rich in Macroeconomic Data

We are getting wholesale differences in the interpretation of the future trajectory of domestic economic growth.

Shift With the Market and Forget About Being a Sage

The question we should ponder is what are the warning signs the market is starting to undergo a change in trend?